bismuth has been researched along with Gastroduodenal Ulcer in 274 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 117 (42.70) | 18.7374 |
| 1990's | 115 (41.97) | 18.2507 |
| 2000's | 27 (9.85) | 29.6817 |
| 2010's | 11 (4.01) | 24.3611 |
| 2020's | 4 (1.46) | 2.80 |
| Authors | Studies |
|---|---|
| Alcedo, J; Amador, J; Bujanda, L; Calvet, X; Castro-Fernández, M; Fernández-Salazar, L; Gené, E; Gisbert, JP; Lanas, Á; Lucendo, AJ; Molina-Infante, J; Nyssen, OP; Pérez-Aisa, A; Puig, I | 1 |
| Li, T; Zhou, Y | 1 |
| Chen, P; Jiang, X; Liu, B; Xu, C; Xu, Q; Zhang, L | 1 |
| Cogdill, AG; Guevara, B | 1 |
| Abbasi, J | 1 |
| Andreev, DN; Dicheva, DT; Maiev, IV; Partzvania-Vinogradova, EV; Yurenev, GL | 1 |
| Gholamrezaei, A; Hashemi, H; Khodadoostan, M; Minakari, M; Shavakhi, A; Shavakhi, S; Tabesh, E; Tabesh, F; Yaghoutkar, A | 1 |
| Abbas, Z; Awan, S; Hamid, S; Jafri, F; Jafri, W; Naz, S; Usman, MW; Yakoob, J | 1 |
| Jang, JY; Jung, HK; Kim, CG; Kim, SG; Lee, H; Lee, HL; Lee, YC; Shin, ES; Shin, WG | 1 |
| Oberhofer, E | 1 |
| Chen, Q; Fu, Q; Liang, X; Liu, W; Lu, H; Xiao, S; Zhang, W | 1 |
| Choe, YH; Chung, IS; Kim, HS; Kim, JI; Kim, JJ; Kim, N | 1 |
| Cheung, DY; Jung, HC; Jung, HY; Jung, SW; Song, HJ | 1 |
| Bytzer, P; Dahlerup, JF; Eriksen, JR; Jarbøl, DE; Rosenstock, S; Wildt, S | 1 |
| Ghadir, MR; Iranikhah, A; Joukar, F; Mansour-Ghanaei, F; Pakdin, A; Shafaghi, A | 1 |
| Agarwal, A; Agrawal, GP; Agrawal, H; Jain, AK | 1 |
| Buzás, GM | 1 |
| Bermejo, F; Boixeda, D; Defarges, V; García-Plaza, A; Hernández-Ranz, F; López-Sanromán, A; Martín-De-Argila, C; Milicua, JM | 1 |
| Kullavanijaya, P; Tangkijvanich, P; Thong-Ngam, D; Treeprasertsuk, S; Wisedopas, N | 1 |
| Berstad, A; Hatlebakk, JG; Olafsson, S | 1 |
| Marshall, B | 1 |
| Chehter, EZ; Eisig, JN; Hashimoto, C; Laudanna, AA; Silva, FM | 1 |
| Laine, L | 2 |
| PYGOTT, F | 1 |
| RUTHER, W | 1 |
| KOHLER, R; VON BOROS, J | 1 |
| HAMILTON, RR | 1 |
| DESMAREZ, JJ; HANS, MJ; LA BARRE, J | 1 |
| KUPERSMITH, IH | 1 |
| KOBIERSKI, R | 1 |
| HAUCH, E | 1 |
| DAMRAU, F | 1 |
| CAMATTE, R; SARLES, H | 1 |
| LA BARRE, J | 1 |
| ANDREJEVIC, M | 1 |
| LEAK, WN | 1 |
| FORSTER, G; GASSMANN, R | 1 |
| HEULLY, F | 1 |
| SAWADA, T | 1 |
| DUIZEND, M; UHRY, P | 1 |
| TKACHENKO, GIa | 1 |
| PEINDARIES, R | 1 |
| KELLEHER, J; MATTS, SG; SWAN, CH | 1 |
| MATTS, SG; SWAN, CH | 1 |
| MILTON, GW | 1 |
| ROI, G | 1 |
| LAMARINA, A; MUSCHIO, R | 1 |
| KUZIUKINA, LA; LAPTEV, AA | 1 |
| KEMP, S | 1 |
| de Boer, WA; Jansen, JB; Janssen, MJ; Laheij, RJ | 1 |
| Huang, JQ; Hunt, RH; Karlberg, J; Lam, SK; Wong, BC; Wong, WM; Zheng, GF | 1 |
| Almeida, JR; Campos, LT; Guerrazzi, F; Lorena, SL; Mesquita, MA; Montes, CG; Zeitune, JM | 1 |
| Cheon, JH; Jung, HC; Kim, JM; Kim, JS; Kim, N; Lee, DH; Lee, JH; Park, MJ; Song, IS | 1 |
| Donovan, JL; Egger, M; Harvey, IM; Harvey, RF; Lane, JA; Murray, LJ; Nair, P; Noble, S | 1 |
| Lule, GN | 1 |
| Lee, KH; Tam, YH; Yeung, CK | 1 |
| Alizadeh, M; Arj, A; Bagheri-Lankarani, K; Bahri-Najafi, R; Dehbashi, N; Emami, MH; Esmaeili, A; Fattahi, MR; Geramizadeh, B; Kaviani, MJ; Saberfiroozi, MM; Taghavi, AR | 1 |
| Baker, DE | 1 |
| Schubert, TT | 1 |
| Zimmerman, TW | 1 |
| Marks, IN | 2 |
| Barr, GD; Piper, DW | 1 |
| Kauffman, GL | 1 |
| Peppercorn, MA | 1 |
| Levine, JB | 1 |
| Cantlay, JS; Glover, SC; Mowat, NA; Weir, J | 1 |
| Bernier, JJ | 1 |
| Ryss, ES | 1 |
| Habior, A; Medrzejewski, W; Tomecki, R | 1 |
| Depczyńska, A; Dzieniszewski, J; Gabryelewicz, A; Gibiński, K; Kosidło, S; Marlicz, K; Milewski, B; Nowak, A | 1 |
| Dube, S; Misra, NP; Tripathi, BM | 1 |
| Fortunat, W | 1 |
| Barbezat, GO | 1 |
| Bathur, FA; Crane, GG; Goulston, KJ; Hilmer, RS; Pheils, MT; Streeter, AM | 1 |
| Brouwers, JR; Tytgat, GN | 1 |
| Cowen, A | 1 |
| Pounder, RE | 1 |
| Chee, YC | 1 |
| Dettmer, A; Domschke, W; Fenner, T; Gregor, M; Hesse, P; Holtmann, G; Miederer, SE; Schentke, KU; Schütz, E; van Husen, N | 1 |
| Berstad, A; Berstad, K; Hatlebakk, JG; Hausken, T; Nesje, LB; Wilhelmsen, I | 1 |
| Golochevskaia, VS; Grebenev, AL; Lapina, TL; Miagkova, LP; Sklianskaia, OA | 1 |
| de Boer, WA; Tytgat, GN | 1 |
| Peterson, WL; Walsh, JH | 1 |
| Börsch, G; Labenz, J | 2 |
| Cohen, MH | 1 |
| Müller, P; Simon, B | 1 |
| Burette, A; Glupczynski, Y | 1 |
| Bajador, E; Gomollón, F | 1 |
| Klotz, O; Treiber, G | 1 |
| Harvey, I; Murray, L | 1 |
| al-Assi, MT; Cole, RA; Genta, RM; Graham, DY; Karttunen, TJ | 1 |
| Allen, A; Copeman, M; Dettmar, PW; Leonard, AJ; Matuz, J; Pearson, JP | 1 |
| Berndt, H | 1 |
| Marshall, BJ | 1 |
| Bertrams, J; Börsch, G; Labenz, J; Rühl, GH | 1 |
| Asaka, M; Horita, S; Inoue, K; Kato, M; Kimura, T; Kudo, M; Meguro, T; Ohtaki, T | 1 |
| Gad, A; Unge, P | 1 |
| Bang, CJ; Berstad, A; Berstad, K; Hatlebakk, JG; Hausken, T; Hjartholm, AS; Hundal, O; Nesje, LB; Nysaeter, G; Wilhelmsen, I | 1 |
| Hentschel, E | 1 |
| al-Assi, MT; Genta, RM; Graham, DY | 1 |
| O'Connor, HJ | 1 |
| Graham, DY; Peura, DA | 1 |
| al-Assi, MT; Genta, RM; Graham, DY; Lew, GM; Ramirez, FC | 1 |
| Bleck, J; Gebel, M; Gladziwa, U; Haruma, K; Manns, M; Schmidt, H; Soudah, B; Wagner, S | 1 |
| Boixeda, D | 1 |
| McGuffey, EC | 1 |
| Beglinger, C | 1 |
| Berstad, A; Berstad, K; Hausken, T; Hundal, O; Weberg, R; Wilhelmsen, I | 1 |
| Genta, RM; Go, MF; Graham, DY; Lew, GM; Rehfeld, JF | 1 |
| Hammar, CH; Jaspersen, D | 1 |
| Gold, B; Huesca, M; Lewin, P; Lingwood, C; Sherman, P | 1 |
| Graham, DY; Hepps, KS; Lew, GM; Ramirez, FC; Saeed, ZA | 1 |
| Ottervanger, JP; Stricker, BH | 1 |
| Nasu, M | 1 |
| Malfertheiner, P | 2 |
| Bell, GD; Powell, KU | 1 |
| Fedotin, MS | 1 |
| Glassman, MS; Halata, MS; Rosioru, C; Schwarz, SM | 1 |
| Karita, M; Nakazawa, T; Okita, K; Sugiyama, T; Tsuda, M | 1 |
| Soll, AH | 1 |
| Talley, NJ | 1 |
| Bang, CJ; Berstad, A; Berstad, K; Hatlebakk, JG; Hausken, T; Hundal, O; Nesje, LB; Nysaeter, G; Olafsson, S; Tefera, S | 1 |
| Burrow, JA; Clark, CK; Merritt, AM; Steible, CK | 1 |
| Arnold, R; Bayerdörffer, E; Behrens, R; Birkner, B; Braden, B; Caspary, WF; Domschke, W; Koletzko, S; Labenz, J; Malfertheiner, P; Menge, H; Rösch, W; Schepp, W; Stolte, M; Strauch, M | 1 |
| de Boer, WA | 1 |
| Bergseth, M; Berstad, A; Berstad, K; Hundal, O; Olafsson, S; Tefera, S; Wilhelmsen, I | 1 |
| Gabryelewicz, A | 1 |
| de Boer, WA; Driessen, WM; Jansz, AR; Tytgat, GN | 1 |
| De Boer, WA; Driessen, WM; Tytgat, GN | 1 |
| Webb, DD | 1 |
| Dammann, HG | 1 |
| Dixon, JS; Drake, FM; Tillman, LA; Wood, JR | 1 |
| De Boer, WA; Driessen, WM; Geuskens, LM; Lai, JY | 1 |
| Hackelsberger, A; Malfertheiner, P | 1 |
| Bonagura, AF; Dabezies, MA | 1 |
| Bardhan, KD | 1 |
| Lux, G | 1 |
| Carmichael, JM; Patchin, GM; Wieland, KA | 1 |
| Goodwin, CS; Mendall, MM; Northfield, TC | 1 |
| Scott, BB; Vautier, G | 1 |
| de Boer, WA; Ouwehand, ME; Schade, RW; Schneeberger, PM; Tytgat, GN; van Etten, RJ; van Unnik, AJ | 1 |
| Hunt, RH | 1 |
| Damianos, AJ; McGarrity, TJ | 1 |
| Forbes, GM | 1 |
| Fock, KM | 1 |
| Myers, D | 1 |
| Barnett, JL; Chey, WD; DelValle, J; Elta, GH; Fisher, L; Hasler, WL; Nostrant, T; Scheiman, JM | 1 |
| Emami, S; Estrada, R; Laine, L; Trujillo, M | 1 |
| Bolin, TD; Engelman, JL; Korman, MG; Pianko, S | 1 |
| Berge, T; Haug, JB; Henriksen, M; Lerang, F; Moum, B; Ragnhildstveit, E; Sandvei, PK; Tolås, P; Whist, JE | 1 |
| Parsonnet, J | 1 |
| Ariano, RE; Tkach, CL | 1 |
| Scott, BB | 1 |
| Breslin, NP; O'Morain, C | 1 |
| Brullet, E; Calvet, X; Campo, R; Comet, R; García, N; Navarro, M | 1 |
| Fendrick, AM; Jeffries, MA; Scheiman, JM | 1 |
| Kleibeuker, JH; Kooy, A; Thijs, JC; van der Wouden, EJ; van Zwet, AA | 1 |
| Bolin, TD; Engelman, JL; Korman, MG; Nicholson, FB | 1 |
| Howden, CW; Hunt, RH | 1 |
| Bellin, EY; Fletcher, DD; Shuter, J; Simone, VJ | 1 |
| Unge, P | 1 |
| Fukuda, Y; Shimoyama, T; Yamamoto, I | 1 |
| Anti, M; Armuzzi, A; Bianchi Porro, G; Cammarota, G; Deltenre, M; Franceschi, F; Gasbarrini, A; Gasbarrini, G; Malfertheiner, P; Mégraud, F; O'Morain, C; Pajares-García, J; Pretolani, S; Quina, M | 1 |
| Choi, CH; Kung, NN; Lai, WM; Lam, KN; Leung, EM; Li, TH; Lui, YH; Ng, PW; Sung, JJ; Yuen, NW | 1 |
| Friedman, LS; Sankey, SL | 1 |
| Aasen, AJ; Berdal, BP; Bergan, T; Dahlgren, A; Gammelsaether, M; Gløgård, C; Klaveness, J | 1 |
| Buring, SM; Doering, PL; Hatton, RC; Winner, LH | 1 |
| Yao, X | 1 |
| Cross, R; Grimley, CE; Illing, RC; Lismore, JR; Loft, DE; Nwokolo, CU; O'sullivan, M; Penny, A; Shebani, M | 1 |
| Chan, FK; Cheng, AF; Chung, SC; Lee, YT; Leung, WK; Ling, TK; Suen, R; Sung, JJ; Wu, JC | 1 |
| Aoyama, N; Kasuga, M; Kita, T; Komada, F; Okumura, K; Shirakawa, K; Tanigawara, Y | 1 |
| Gurer, I; Hilmioglu, F; Ozyilkan, E; Sare, M; Taskin, V | 1 |
| Akhunov, ED; Farztdinov, KM; Katayev, VA; Kazykhanov, NS; Khusnutdinov, SM; Nijevitch, AA; Sataev, VU | 1 |
| Cabezudo, JG; Ducóns, J; Gomollon, F; Guirao, R; Montoro, M; Santolaria, S | 1 |
| Eshraghian, MR; Fazel, A; Malekzadeh, R; Massarrat, S; Sotudehmanesh, R; Ziad-Alizadeh, B | 1 |
| Chiba, N; Hunt, RH; Thomson, AB | 1 |
| Bardhan, KD; Mitchell, TR; Morris, P; Morton, D; Perry, MJ; Roberts, PM; Rowland, A; Sanders, DS; Thompson, M | 1 |
| Amini, M; Kamalian, N; Kaviani, MJ; Malekzadeh, R; Massarrat, S; Sotoudeh, M; Vahedi, H | 1 |
| Gisbert, JL; Gisbert, JP; Marcos, S; Pajares, JM | 1 |
| Halter, F; Witzel, L | 1 |
| Hetzel, D; Shearman, DJ | 1 |
| Papasomatious, A; Polymeropoulos, PS; Poulantzas, J | 1 |
| Ippoliti, A; Peterson, W | 1 |
| Bank, S; Barbezat, GO; Mekel, RC; Novis, BH; Serfontein, WJ | 1 |
| Abrahamsson, H; Dotevall, G | 1 |
| Langman, MJ | 1 |
| Bozhiianov, V; Brailski, KH; Kadiian, KH | 1 |
| Grossman, MI; Isenberg, JI; Meyer, JH; Passaro, E; Schwabe, A; Sturdevant, RA | 1 |
| Shearman, DJ | 1 |
| Avery, GS; Brogden, RN; Pinder, RM; Sawyer, PR; Speight, TM | 1 |
| Burrous, SE; Castellion, AW; Goldenberg, MM; Honkomp, LJ | 1 |
| Berard, E; Gallavardin, M | 1 |
| Gütz, HJ | 1 |
| Bergeron, P; Gorce, D; Tournier, C; Tournut, B | 1 |
| Gorshkov, VA; Masevich, TsG | 1 |
| Garner, A | 1 |
| Cave, DR | 1 |
| Dresow, B; Fischer, R; Gabbe, EE; Heinrich, HC; Wendel, J | 1 |
| Barnett, C; Peterson, WL; Yates, S | 1 |
| Casaubón-Garcín, P; Cervantes, R; Ramírez-Mayans, J; Tovar-Calderón, S | 1 |
| Eberhardt, R; Kuhn, D; Mateblowski, M; Topfmeier, P | 1 |
| Peterson, WL | 1 |
| Raedsch, R | 1 |
| Gorodinskaia, VS; Il'chenko, AA; Zhukhovitskiĭ, BG; Zurabishvili, NG | 1 |
| Braden, GL; Lefton, HB; Pilchman, J | 1 |
| Nanivadekar, SA | 1 |
| Gorbach, SL | 1 |
| Loizeau, E | 1 |
| Börsch, GM; Graham, DY | 1 |
| Bernades, P; Cerf, M; Devars du Mayne, JF | 1 |
| Amouretti, M | 1 |
| Furugård, K; Gad, A; Hradsky, M; Malmodin, B | 1 |
| May, B | 1 |
| Bogdanova, AV; Dorofeev, AA; Klemashev, IS; Liz'ko, NN; Stepanov, VA | 1 |
| Holt, KM; Isenberg, JI | 1 |
| Koelz, HR | 1 |
| Blum, AL | 1 |
| Bertaccini, G; Coruzzi, G | 1 |
| Misiewicz, JJ | 1 |
| Börsch, G; Rühl, GH | 1 |
| Benfield, P; Monk, JP; Wagstaff, AJ | 1 |
| Börsch, G | 2 |
| Colin-Jones, DG | 1 |
| Brzozowski, T; Drozdowicz, D; Konturek, SJ; Radecki, T; Stachura, J | 1 |
| Tytgat, GN | 2 |
| Bielanski, W; Brzozowski, T; Dembinski, A; Drozdowicz, D; Konturek, SJ; Warzecha, Z | 1 |
| Waghorn, DJ | 1 |
| Daschner, F; Engels, I; Kappstein, I; Krieg, N; Pfisterer, J; Reuschenbach, K; Vogel, W | 1 |
| Konturek, SJ | 1 |
| Bader, JP | 1 |
| Börsch, G; Schmidt, G | 1 |
| Rösch, W | 2 |
| Coghill, SB; Soutar, RL | 1 |
| Dudley, FJ; McCarthy, P; McLean, AJ | 1 |
| Deveney, CW; Deveney, KE | 1 |
| Platt, D | 1 |
| Paullus, GE | 1 |
| Kravchenko, NM; Shkol'nik, ML | 1 |
| Dzharimov, AIa; Petrova, AN | 1 |
| Marano, R; Martino Bonomo, G; Nacchiero, M | 1 |
| Bourdais, JP; Hureau, J | 1 |
| Cruickshank, GW; Wright, T | 1 |
| Artemkina, LN; Minochkina, LA; Shishliannikov, MI | 1 |
| Kallmeyer, JC; Weiss, G | 1 |
| Desai, DC; Gibbs, JO; Moeller, HC; Puletti, EJ; Rider, JA | 1 |
| Sobotka, JJ | 1 |
| Lanza, FL | 1 |
| Ruas, J; Sardet, MB | 1 |
| Négret, JP | 1 |
| Kraheck, G | 1 |
| Arias Vallejo, E | 1 |
| Onishuk, VF; Sakharchuk, II | 1 |
| Hillemand, P | 1 |
| Mamikonian, RS; Mnatsaknov, TS; Tumanian, AM | 1 |
71 review(s) available for bismuth and Gastroduodenal Ulcer
| Article | Year |
|---|---|
V Spanish Consensus Conference on Helicobacter pylori infection treatment.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer; Proton Pump Inhibitors | 2022 |
Efficacy and safety of bifidobacterium quadruple viable tablets in the treatment of Helicobacter pylori-infected peptic ulcer or gastritis patients: a systematic review and meta-analysis.
Topics: Abdominal Pain; Bifidobacterium; Bismuth; Gastritis; Helicobacter pylori; Humans; Peptic Ulcer; Tablets | 2023 |
Helicobacter pylori: A Review of Current Diagnostic and Management Strategies.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens, Bacterial; Biopsy; Bismuth; Breath Tests; Clarithromycin; Culture Techniques; Doxycycline; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Feces; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Nitro Compounds; Organometallic Compounds; Peptic Ulcer; Polymerase Chain Reaction; Proton Pump Inhibitors; Rifabutin; Salicylates; Salvage Therapy; Serologic Tests; Stomach Neoplasms; Tetracycline; Thiazoles; Treatment Outcome; Urea | 2020 |
Diagnosis and treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Antidiarrheals; Bismuth; Clarithromycin; Denmark; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Organometallic Compounds; Peptic Ulcer; Proton Pump Inhibitors; Salicylates; Stomach Neoplasms; Tetracycline | 2011 |
[Helicobacter pylori - 2012].
Topics: Algorithms; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Emigrants and Immigrants; Endoscopy, Gastrointestinal; Europe; Helicobacter Infections; Helicobacter pylori; Humans; Hungary; In Situ Hybridization, Fluorescence; Levofloxacin; Ofloxacin; Peptic Ulcer; Polymerase Chain Reaction; Stomach Neoplasms | 2012 |
Is it time for quadruple therapy to be first line?
Topics: Amoxicillin; Antacids; Anti-Infective Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Time Factors | 2003 |
Do patients with non-ulcer dyspepsia respond differently to Helicobacter pylori eradication treatments from those with peptic ulcer disease? A systematic review.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine; Treatment Outcome | 2005 |
Pylera plus omeprazole: quadruple treatment for Helicobacter pylori.
Topics: Antacids; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Capsules; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer; Tetracycline | 2008 |
Update in treatment of peptic ulcer disease.
Topics: Adult; Aged; Alcohol Drinking; Aluminum; Antacids; Anti-Ulcer Agents; Aspirin; Bismuth; Cimetidine; Female; Humans; Male; Organometallic Compounds; Peptic Ulcer; Ranitidine; Recurrence; Smoking; Sucralfate; Vagotomy, Proximal Gastric | 1984 |
Current therapy in peptic ulcer.
Topics: Antacids; Bismuth; Carbenoxolone; Cimetidine; Drug Therapy, Combination; Histamine H2 Antagonists; Humans; Peptic Ulcer; Recurrence; Rest; Smoking; Sulpiride | 1980 |
Drug therapy of peptic ulcer disease.
Topics: Aluminum; Antacids; Anti-Ulcer Agents; Bismuth; Carbenoxolone; Cimetidine; Gastric Mucosa; Histamine H2 Antagonists; Humans; Organometallic Compounds; Parasympatholytics; Peptic Ulcer; Recurrence; Sucralfate | 1983 |
Pharmacologic options for the control of peptic ulcer disease.
Topics: Antacids; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Carbenoxolone; Cimetidine; Duodenal Ulcer; Histamine H2 Antagonists; Humans; Omeprazole; Parasympatholytics; Peptic Ulcer; Prostaglandins, Synthetic; Ranitidine; Risk; Stomach Neoplasms; Surface-Active Agents | 1984 |
[Selective and locally-acting drugs in the treatment of peptic ulcer].
Topics: Acetazolamide; Aluminum; Anti-Ulcer Agents; Benzodiazepinones; Bismuth; Carbenoxolone; Cimetidine; Epoprostenol; Humans; Organometallic Compounds; Peptic Ulcer; Pirenzepine; Prostaglandins E; Sucralfate | 1984 |
The treatment of Helicobacter pylori infection in the management of peptic ulcer disease.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer; Recurrence | 1995 |
Treating peptic ulcer: an ongoing challenge.
Topics: Antacids; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Metronidazole; Organometallic Compounds; Peptic Ulcer; Salicylates; Tetracycline | 1995 |
[Status of ranitidine in eradication of Helicobacter pylori].
Topics: Amoxicillin; Bismuth; Clinical Trials as Topic; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer; Ranitidine | 1995 |
Helicobacter pylori: the place of the new macrolides in the eradication of the bacteria in peptic ulcer disease.
Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Omeprazole; Peptic Ulcer; Treatment Outcome; Uncoupling Agents | 1995 |
[Controversies and trends in ulcer therapy. 2: Prevention of recurrence].
Topics: Adult; Aged; Bismuth; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Long-Term Care; Male; Middle Aged; Omeprazole; Peptic Ulcer; Recurrence; Sucralfate | 1993 |
[Management of the peptic ulcer patient in the Helicobacter pylori age].
Topics: Algorithms; Antacids; Anti-Bacterial Agents; Biopsy; Bismuth; Breath Tests; Child; Drug Therapy, Combination; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Immunologic Techniques; Lymphoma, Non-Hodgkin; Metronidazole; Peptic Ulcer; Stomach Neoplasms | 1994 |
Antibacterial therapy of Helicobacter pylori-associated peptic ulcer disease: a new strategy. The Swedes go for it.
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer | 1994 |
Helicobacter pylori in peptic ulcer disease.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer; United States | 1994 |
[Current therapy of Helicobacter pylori-induced chronic gastritis and/or peptic ulcer].
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer | 1994 |
The role of Helicobacter pylori in peptic ulcer disease.
Topics: Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer | 1994 |
Helicobacter pylori: consensus reached: peptic ulcer is on the way to becoming an historic disease.
Topics: Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Organometallic Compounds; Peptic Ulcer; Salicylates; Tetracycline; United States | 1994 |
[Treatment of Helicobacter pylori infection in adults].
Topics: Antacids; Anti-Bacterial Agents; Bismuth; Drug Resistance, Microbial; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Metronidazole; Peptic Ulcer; Recurrence; Treatment Outcome | 1994 |
[Helicobacter pylori infections].
Topics: Amphotericin B; Bismuth; Clarithromycin; Drug Resistance, Microbial; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer; Tetracyclines | 1993 |
Compliance, adverse events and antibiotic resistance in Helicobacter pylori treatment.
Topics: Amoxicillin; Bismuth; Cimetidine; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Patient Compliance; Peptic Ulcer; Tinidazole | 1993 |
Eradication of Helicobacter pylori and its effect in peptic ulcer disease.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Campylobacter Infections; Drug Therapy, Combination; Humans; Omeprazole; Peptic Ulcer; Recurrence | 1993 |
Helicobacter pylori and peptic ulcer disease. Reexamining the therapeutic approach.
Topics: Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Peptic Ulcer; Salicylates | 1993 |
Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology.
Topics: Antacids; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Biopsy; Bismuth; Breath Tests; Contraindications; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Metronidazole; Misoprostol; Peptic Ulcer; Predictive Value of Tests; Proton Pump Inhibitors; Recurrence | 1996 |
Modern management of dyspepsia.
Topics: Adult; Aged; Antacids; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Bismuth; Child; Cholelithiasis; Chronic Disease; Cisapride; Diagnosis, Differential; Domperidone; Dopamine Antagonists; Dyspepsia; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Metoclopramide; Peptic Ulcer; Piperidines; Stomach Neoplasms | 1996 |
How to achieve a near 100% cure rate for H. pylori infection in peptic ulcer patients. A personal viewpoint.
Topics: Anti-Bacterial Agents; Bismuth; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer | 1996 |
Bismuth therapy for Helicobacter pylori infection. A review of five years experience at a university hospital in Norway.
Topics: Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Hospitals, University; Humans; Metronidazole; Norway; Oxytetracycline; Peptic Ulcer; Stomach Diseases; Urea; Urease | 1996 |
Critical evaluation of the treatment of peptic ulcer diseases associated with Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer; Tetracyclines; Tinidazole | 1996 |
[Helicobacter pylori eradication: triple therapy versus dual therapy].
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer; Tetracycline; Tinidazole; Treatment Outcome | 1996 |
Review article: safety of bismuth in the treatment of gastrointestinal diseases.
Topics: Bismuth; Dyspepsia; Gastrointestinal Agents; Gastrointestinal Diseases; Humans; Peptic Ulcer; Ranitidine | 1996 |
A risk-benefit assessment of drugs used in the eradication of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Nitroimidazoles; Omeprazole; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Risk Assessment; Tetracyclines | 1996 |
Helicobacter pylori infection. The importance of eradication in patients with gastric disease.
Topics: Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer | 1996 |
Triple therapy as a cure for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Sulfoxides | 1996 |
Helicobacter pylori infection.
Topics: Anti-Bacterial Agents; Bismuth; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer | 1997 |
Peptic ulcer disease: defining the treatment strategies in the era of Helicobacter pylori.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer; Proton Pump Inhibitors | 1997 |
Treatment strategies for Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Protein Synthesis Inhibitors; Salicylates; Tetracycline | 1997 |
Review: Helicobacter pylori. Current issues and new directions.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Bismuth; Drug Therapy, Combination; Dyspepsia; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Peptic Ulcer; Stomach Neoplasms | 1997 |
Peptic ulcer disease in the 1990s: an Asian perspective.
Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Asia; Bismuth; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer | 1997 |
Helicobacter pylori.
Topics: Adenocarcinoma; Anti-Bacterial Agents; Bismuth; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma; Peptic Ulcer; Stomach Neoplasms | 1998 |
Antimicrobial treatment of H. pylori infection--a pooled efficacy analysis of eradication therapies.
Topics: Antacids; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Meta-Analysis as Topic; Peptic Ulcer | 1998 |
[History of the treatment of Helicobacter pylori and clinical efficacy].
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clinical Trials as Topic; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer; Practice Guidelines as Topic; Proton Pump Inhibitors | 1999 |
New concepts concerning management of Helicobacter pylori infection: 2 years after the Maastricht Consensus Report.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Neoplasms; Endoscopy, Digestive System; Enzyme Inhibitors; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Organometallic Compounds; Peptic Ulcer; Practice Guidelines as Topic; Proton Pump Inhibitors; Ranitidine; Stomach Neoplasms | 1998 |
Formulary management of antiulcer drugs: clinical considerations.
Topics: Anti-Ulcer Agents; Bismuth; Cost-Benefit Analysis; Humans; Parasympatholytics; Peptic Ulcer; Prostaglandins, Synthetic; Recurrence | 1994 |
Discontinuation rates of Helicobacter pylori treatment regimens: a meta-analysis.
Topics: Antacids; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Enzyme Inhibitors; Gastrointestinal Agents; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Multivariate Analysis; Patient Compliance; Peptic Ulcer; Proton Pump Inhibitors | 1999 |
Ranitidine bismuth citrate.
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter pylori; Humans; Peptic Ulcer; Ranitidine | 2001 |
The medical management of peptic ulcer.
Topics: Antacids; Anti-Ulcer Agents; Bismuth; Carbenoxolone; Cimetidine; Histamine H2 Antagonists; Humans; Organometallic Compounds; Parasympatholytics; Peptic Ulcer; Smoking | 1979 |
The pharmacology of peptic ulcer disease.
Topics: Antacids; Anti-Ulcer Agents; Bismuth; Carbenoxolone; Cimetidine; Clinical Trials as Topic; Costs and Cost Analysis; Gastric Juice; Gastrins; Humans; Parasympatholytics; Peptic Ulcer; Recurrence | 1979 |
[Future perspectives of ulcer therapy].
Topics: Anti-Ulcer Agents; Bismuth; Forecasting; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer | 1992 |
Therapeutic approaches to recurrent peptic ulcer disease.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Organometallic Compounds; Peptic Ulcer; Recurrence; Salicylates | 1992 |
[Helicobacter pylori: can it be a contributing factor in peptic ulcer in childhood?].
Topics: Anti-Bacterial Agents; Bismuth; Child; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Peptic Ulcer; Salicylates | 1991 |
Pathogenesis and therapy of peptic ulcer disease.
Topics: Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Histamine H2 Antagonists; Humans; Peptic Ulcer; Prostaglandins; Sucralfate | 1990 |
[Bismuth therapy in gastroenterology].
Topics: Bismuth; Diarrhea; Gastritis; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer | 1991 |
Bismuth compounds in the treatment of peptic ulcer: a review.
Topics: Anti-Ulcer Agents; Bismuth; Humans; Organometallic Compounds; Peptic Ulcer; Recurrence | 1990 |
Bismuth therapy in gastrointestinal diseases.
Topics: Bismuth; Campylobacter; Chemical Phenomena; Chemistry; Diarrhea; Humans; Peptic Ulcer | 1990 |
The who's and when's of therapy for Helicobacter pylori.
Topics: Anti-Bacterial Agents; Bismuth; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer | 1990 |
Sucralfate and other non-antisecretory agents in the treatment of peptic ulcer disease.
Topics: Animals; Anti-Ulcer Agents; Bismuth; Humans; Peptic Ulcer; Sucralfate | 1989 |
Therapeutic approach to ulcer healing.
Topics: Aluminum; Antacids; Anti-Ulcer Agents; Antidepressive Agents; Benzodiazepinones; Bismuth; Colloids; Drug Administration Schedule; Duodenal Ulcer; Duodenoscopy; Histamine H2 Antagonists; Humans; Peptic Ulcer; Pirenzepine; Recurrence; Stomach Ulcer; Sucralfate | 1985 |
Pharmacology of the treatment of peptic ulcer disease.
Topics: Aluminum; Animals; Antacids; Anti-Ulcer Agents; Bismuth; Brain; Carbenoxolone; Forecasting; Gastric Acid; Gastric Mucosa; Gastrointestinal Motility; Histamine H2 Antagonists; Humans; Intestinal Mucosa; Organometallic Compounds; Parasympatholytics; Peptic Ulcer; Sucralfate | 1985 |
Site-protective agents.
Topics: Anti-Ulcer Agents; Bismuth; Carbenoxolone; Glycyrrhiza; Humans; Peptic Ulcer; Plant Extracts; Plants, Medicinal; Sucralfate | 1988 |
Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.
Topics: Anti-Ulcer Agents; Bismuth; Cimetidine; Clinical Trials as Topic; Half-Life; Humans; Kinetics; Organometallic Compounds; Peptic Ulcer; Ranitidine; Smoking | 1988 |
[Therapy of peptic ulcer. Bismuth salts].
Topics: Anti-Ulcer Agents; Bismuth; Clinical Trials as Topic; Humans; Peptic Ulcer | 1988 |
[Campylobacter pylori and therapy with bismuth salts].
Topics: Bismuth; Campylobacter; Campylobacter Infections; Gastritis; Humans; Peptic Ulcer | 1988 |
There is more to healing ulcers than suppressing acid.
Topics: Aluminum; Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Gastric Acid; Humans; Organometallic Compounds; Pepsin A; Peptic Ulcer; Prostaglandins; Sucralfate | 1986 |
Campylobacter pyloridis: a new organism to explain an old problem?
Topics: Bismuth; Campylobacter; Campylobacter Infections; Female; Gastritis; Humans; Middle Aged; Peptic Ulcer | 1987 |
Medical treatment of peptic ulcers.
Topics: Aluminum; Antacids; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Cimetidine; Humans; Omeprazole; Parasympatholytics; Peptic Ulcer; Prostaglandins; Ranitidine; Recurrence; Sucralfate; Zollinger-Ellison Syndrome | 1985 |
63 trial(s) available for bismuth and Gastroduodenal Ulcer
| Article | Year |
|---|---|
Evaluation of the efficacy and safety of the hybrid scheme for eradication therapy of Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Antacids; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Peptic Ulcer; Prospective Studies; Treatment Outcome | 2018 |
The effects of multistrain probiotic compound on bismuth-containing quadruple therapy for Helicobacter pylori infection: a randomized placebo-controlled triple-blind study.
Topics: Adult; Aged; Anti-Bacterial Agents; Bismuth; Breath Tests; Female; Helicobacter Infections; Humans; Male; Middle Aged; Peptic Ulcer; Placebos; Probiotics; Treatment Outcome; Urea | 2013 |
Rescue Therapy for Helicobacter pylori Eradication: A Randomized Non-Inferiority Trial of Amoxicillin or Tetracycline in Bismuth Quadruple Therapy.
Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Medication Adherence; Metronidazole; Middle Aged; Peptic Ulcer; Proton Pump Inhibitors; Tetracycline; Treatment Failure; Treatment Outcome; Young Adult | 2016 |
Furazolidone, amoxicillin and omeprazole with or without bismuth for eradication of Helicobacter pylori in peptic ulcer disease.
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Infective Agents, Local; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Follow-Up Studies; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Peptic Ulcer; Treatment Outcome | 2011 |
Efficacy of quadruple therapy with pantoprazole, bismuth, tetracycline and metronidazole as rescue treatment for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Pantoprazole; Peptic Ulcer; Prospective Studies; Sulfoxides; Tetracycline; Treatment Failure; Treatment Outcome | 2002 |
Effectiveness of ranitidine bismuth citrate based triple therapy for treating Helicobacter pylori.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Peptic Ulcer; Prospective Studies; Ranitidine; Stomach; Thailand; Treatment Outcome | 2002 |
Patients with endoscopic gastritis and/or duodenitis improve markedly following eradication of Helicobacter pylori, although less so than patients with ulcers.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenitis; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Oxytetracycline; Peptic Ulcer; Ranitidine; Spiramycin; Time Factors | 2002 |
The influence of pretreatment on cure rates of Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Tetracycline | 2004 |
One-week dual therapy with ranitidine bismuth citrate and clarithromycin for the treatment of Helicobacter pylori infection in Brazilian patients with peptic ulcer.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Brazil; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Peptic Ulcer; Ranitidine; Treatment Outcome | 2005 |
Impact of Helicobacter pylori eradication on dyspepsia, health resource use, and quality of life in the Bristol helicobacter project: randomised controlled trial.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Costs and Cost Analysis; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Mass Screening; Middle Aged; Patient Acceptance of Health Care; Peptic Ulcer; Quality of Life; Ranitidine | 2006 |
Seven-day is more effective than 4-day ranitidine bismuth citrate-based triple therapy in eradication of Helicobacter pylori in children: a prospective randomized study.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Child; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Peptic Ulcer; Prospective Studies; Ranitidine | 2006 |
Does delayed gastric emptying shorten the H pylori eradication period? A double blind clinical trial.
Topics: Antacids; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Dopamine Agents; Double-Blind Method; Dyspepsia; Gastric Emptying; Helicobacter Infections; Helicobacter pylori; Humans; Levodopa; Metronidazole; Omeprazole; Peptic Ulcer; Sucrose; Tetracycline; Treatment Outcome | 2006 |
Oral tripotassium-dicitratobismuthate in gastric and duodenal ulceration. A double-blind controlled trial.
Topics: Adult; Aged; Bismuth; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Organometallic Compounds; Palliative Care; Peptic Ulcer; Prospective Studies; Random Allocation; Stomach Ulcer | 1983 |
[Clinical evaluation of De-Nol].
Topics: Anti-Ulcer Agents; Bismuth; Clinical Trials as Topic; Humans; Organometallic Compounds; Peptic Ulcer; Wound Healing | 1984 |
[Tripotassium-dicitrato bismuthate in the treatment of peptic ulcer and the prevention of its recurrence].
Topics: Adult; Aged; Anti-Ulcer Agents; Bismuth; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Organometallic Compounds; Peptic Ulcer; Recurrence | 1984 |
Double blind randomised study of tripotassium-di-citrato-bismuthate in the treatment of peptic ulcer.
Topics: Adult; Aged; Anti-Ulcer Agents; Bismuth; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Organometallic Compounds; Peptic Ulcer; Recurrence | 1984 |
Present and future treatment of peptic ulcer and potential role of DE-NOL.
Topics: Antacids; Anti-Ulcer Agents; Bismuth; Clinical Trials as Topic; Disease Models, Animal; Duodenal Ulcer; Gastrointestinal Hemorrhage; Humans; Organometallic Compounds; Peptic Ulcer; Recurrence; Stomach Ulcer | 1982 |
Spiramycin in triple therapy of Helicobacter pylori-associated peptic ulcer disease. An open pilot study with 12-month follow-up.
Topics: Adult; Aged; Bismuth; Breath Tests; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Oxytetracycline; Peptic Ulcer; Spiramycin; Treatment Outcome | 1995 |
Azithromycin triple therapy for Helicobacter pylori infection: azithromycin, tetracycline, and bismuth.
Topics: Azithromycin; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Organometallic Compounds; Peptic Ulcer; Ranitidine; Salicylates; Tetracycline | 1995 |
Causal role of Helicobacter pylori in peptic ulcer relapse.
Topics: Aged; Amoxicillin; Bismuth; Chi-Square Distribution; Drug Therapy, Combination; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Leukocytes; Male; Metronidazole; Omeprazole; Peptic Ulcer; Prospective Studies; Proton Pumps; Recurrence | 1994 |
Short report: omeprazole-tetracycline combinations are inadequate as therapy for Helicobacter pylori infection.
Topics: Adult; Aged; Aged, 80 and over; Bismuth; Dose-Response Relationship, Drug; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Stomach Ulcer; Tetracycline | 1994 |
Helicobacter pylori eradication with bismuth subnitrate, oxytetracycline and metronidazole in patients with peptic ulcer disease.
Topics: Adult; Aged; Antacids; Bismuth; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Oxytetracycline; Peptic Ulcer; Recurrence | 1994 |
Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease.
Topics: Adult; Aged; Bismuth; Drug Therapy, Combination; Follow-Up Studies; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Ranitidine; Recurrence; Salicylates; Tetracycline | 1993 |
Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Oxytetracycline; Palliative Care; Peptic Ulcer; Ranitidine; Treatment Outcome | 1996 |
Effect of aluminum hydroxide/magnesium hydroxide antacid and bismuth subsalicylate on gastric pH in horses.
Topics: Administration, Oral; Aluminum Hydroxide; Animals; Antacids; Bismuth; Drug Therapy, Combination; Female; Gastric Acidity Determination; Gastric Mucosa; Horse Diseases; Horses; Hydrogen-Ion Concentration; Magnesium Hydroxide; Male; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Salicylates; Stomach | 1996 |
Quadruple therapy compared with dual therapy for eradication of Helicobacter pylori in ulcer patients: results of a randomized prospective single-centre study.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Bismuth; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Prospective Studies; Tetracycline | 1995 |
Only four days of quadruple therapy can effectively cure Helicobacter pylori infection.
Topics: Adult; Aged; Aged, 80 and over; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Dyspepsia; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Tetracycline | 1995 |
Long-term follow-up after cure of Helicobacter pylori infection with 4 days of quadruple therapy.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Metronidazole; Omeprazole; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Recurrence; Serologic Tests; Tetracycline | 1996 |
One-day intensified lansoprazole-quadruple therapy for cure of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Diarrhea; Drug Therapy, Combination; Dyspepsia; Endoscopy, Gastrointestinal; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Tetracycline | 1997 |
Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Combinations; Drug Resistance, Microbial; Dyspepsia; Evaluation Studies as Topic; Feces; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Medical Records; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Patient Compliance; Peptic Ulcer; Proton Pump Inhibitors; Salicylates; Taste Disorders | 1997 |
Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Bismuth; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Combinations; Female; Follow-Up Studies; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine; Salicylates; Tetracycline; Urea | 1997 |
Sucralfate as an alternative to bismuth in quadruple therapy for Helicobacter pylori eradication.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Sucralfate; Tetracycline | 1997 |
Bismuth-containing single-antibiotic 1-week triple therapy for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Adolescent; Adult; Aged; Aged, 80 and over; Antacids; Anti-Bacterial Agents; Anus Diseases; Bismuth; Breath Tests; Carbon Isotopes; Clarithromycin; Diarrhea; Drug Therapy, Combination; Enzyme Inhibitors; Female; Hallucinations; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Nausea; Omeprazole; Peptic Ulcer; Pregnancy; Protein Synthesis Inhibitors; Proton Pump Inhibitors; Taste Disorders; Time Factors; Tongue Diseases; Treatment Outcome; Urea; Vomiting | 1998 |
Two-day quadruple therapy for cure of Helicobacter pylori infection: a comparative, randomized trial.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Administration Schedule; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Treatment Outcome | 1998 |
Helicobacter pylori eradication: kill the bug and save the pill?
Topics: Antacids; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Bismuth; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Naproxen; Peptic Ulcer; Prospective Studies; Risk Factors; Single-Blind Method; Tetracycline | 1998 |
One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Ranitidine; Time Factors; Treatment Failure | 1998 |
Lansoprazole quadruple therapy is effective in curing Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Tetracycline; Treatment Outcome | 1998 |
One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Ranitidine; Tetracycline | 1999 |
Comparison of two 3-day Helicobacter pylori eradication regimens with a standard 1-week regimen.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Bismuth; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Ranitidine; Treatment Outcome | 1999 |
One-week ranitidine bismuth citrate in combinations with metronidazole, amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection: the RBC-MACH study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Combinations; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Penicillins; Peptic Ulcer; Prospective Studies; Ranitidine; Treatment Outcome | 1999 |
Effect of Helicobacter pylori eradication on peptic ulcer disease complicated with outlet obstruction.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Outlet Obstruction; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Salicylates; Tetracycline; Treatment Outcome | 2000 |
Helicobacter pylori infection in childhood: results of management with ranitidine bismuth citrate plus amoxicillin and tinidazole.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Child; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Male; Peptic Ulcer; Ranitidine; Tinidazole | 2000 |
A randomized controlled comparison of three quadruple therapy regimens in a population with low Helicobacter pylori eradication rates.
Topics: Adult; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Peptic Ulcer; Treatment Outcome | 2001 |
Ranitidine bismuth citrate with clarithromycin alone or with metronidazole for the eradication of Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Carbon Isotopes; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Ranitidine; Treatment Outcome; Urea; Urease | 2001 |
Various durations of a standard regimen (amoxycillin, metronidazole, colloidal bismuth sub-citrate for 2 weeks or with additional ranitidine for 1 or 2 weeks) on eradication of Helicobacter pylori in Iranian peptic ulcer patients. A randomized controlled
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Biopsy, Needle; Bismuth; Breath Tests; Drug Administration Schedule; Drug Therapy, Combination; Esophagoscopy; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Ranitidine; Urea | 2001 |
Helicobacter pylori eradication therapy is more effective in peptic ulcer than in non-ulcer dyspepsia.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Penicillins; Peptic Ulcer; Ranitidine; Retrospective Studies | 2001 |
A double blind evaluation of the effect of tri-potassium di-citrato bismuthate in peptic ulcer.
Topics: Adolescent; Adult; Aged; Bismuth; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Peptic Ulcer | 1978 |
The pharmacology of peptic ulcer disease.
Topics: Antacids; Anti-Ulcer Agents; Bismuth; Carbenoxolone; Cimetidine; Clinical Trials as Topic; Costs and Cost Analysis; Gastric Juice; Gastrins; Humans; Parasympatholytics; Peptic Ulcer; Recurrence | 1979 |
Bicitropeptide, antacid and placebo in gastric and duodenal ulceration. A two-centre, double-blind, comparative endoscopic study.
Topics: Adult; Antacids; Bismuth; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Duodenal Ulcer; Female; Humans; Male; Peptic Ulcer; Placebos; Proteins | 1979 |
Pharmacological and clinical aspects of some drugs used in peptic ulcer treatment.
Topics: Anti-Ulcer Agents; Benzodiazepinones; Bismuth; Carbenoxolone; Clinical Trials as Topic; Double-Blind Method; Glycyrrhiza; Humans; Peptic Ulcer; Piperazines; Plants, Medicinal; Sulpiride | 1979 |
[Clinical trial of the preparation Caved S in treating peptic ulcer].
Topics: Adult; Aluminum Hydroxide; Antacids; Bismuth; Bulgaria; Clinical Trials as Topic; Drug Combinations; Drug Evaluation; Duodenal Ulcer; Female; Glycyrrhiza; Humans; Male; Middle Aged; Peptic Ulcer; Plants, Medicinal; Stomach Ulcer; Tablets | 1975 |
[Treatment of gastroduodenal ulcer with plasmutan].
Topics: Adult; Aged; Aminocaproates; Anti-Inflammatory Agents; Bismuth; Drug Combinations; Drug Evaluation; Female; Humans; Male; Middle Aged; Peptic Ulcer | 1975 |
[Clinical, radiological and endoscopic evaluation of the use of plasmutan in gastro-intestinal ulcerous diseases].
Topics: Adult; Aged; Aminocaproates; Bismuth; Drug Combinations; Female; Gastritis; Gastrointestinal Agents; Hernia, Hiatal; Humans; Male; Middle Aged; Peptic Ulcer | 1975 |
Enteric-coated charcoal as a means of blinding studies comparing bismuth and H2-receptor antagonists.
Topics: Administration, Oral; Adult; Bismuth; Charcoal; Color; Double-Blind Method; Drug Therapy, Combination; Feces; Female; Humans; Male; Middle Aged; Peptic Ulcer; Ranitidine; Reference Values; Tablets, Enteric-Coated | 1992 |
Ulcer relapse rates following initial treatment with bismuth subnitrate as compared with cimetidine respectively.
Topics: Adult; Aged; Antacids; Bismuth; Cimetidine; Endoscopy, Gastrointestinal; Female; Helicobacter pylori; Humans; Male; Middle Aged; Peptic Ulcer; Recurrence | 1991 |
Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.
Topics: Anti-Ulcer Agents; Bismuth; Cimetidine; Clinical Trials as Topic; Half-Life; Humans; Kinetics; Organometallic Compounds; Peptic Ulcer; Ranitidine; Smoking | 1988 |
[Therapy of peptic ulcer. Bismuth salts].
Topics: Anti-Ulcer Agents; Bismuth; Clinical Trials as Topic; Humans; Peptic Ulcer | 1988 |
Colloidal bismuth subcitrate in peptic ulcer disease.
Topics: Anti-Ulcer Agents; Bismuth; Clinical Trials as Topic; Duodenal Ulcer; Humans; Organometallic Compounds; Peptic Ulcer; Stomach Ulcer | 1986 |
Caved-S and Ulcedal for peptic ulcer.
Topics: Aluminum Hydroxide; Bismuth; Clinical Trials as Topic; Drug Combinations; Duodenal Ulcer; Glycyrrhiza; Humans; Magnesium Hydroxide; Peptic Ulcer; Plant Extracts; Plants, Medicinal; Sodium Bicarbonate; Stomach Ulcer | 1973 |
[Therapy of ulcerous disease with a preparation of colloidal bismuth].
Topics: Adult; Bismuth; Clinical Trials as Topic; Colloids; Drug Evaluation; Female; Humans; Male; Middle Aged; Peptic Ulcer | 1974 |
[Treatment of gastroduodenal ulcers through the combination calcium acexamate-light bismuth nitrate].
Topics: Acetates; Adult; Aged; Amines; Bismuth; Calcium; Caproates; Clinical Trials as Topic; Drug Combinations; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Nitrates; Peptic Ulcer; Stomach Ulcer | 1973 |
Pilot trial of a colloidal bismuth preparation in the treatment of peptic ulcer.
Topics: Aged; Bismuth; Clinical Trials as Topic; Colloids; Female; Humans; Male; Middle Aged; Peptic Ulcer | 1968 |
An evaluation of a bismuth aluminate antacid.
Topics: Aluminum; Antacids; Bismuth; Clinical Trials as Topic; Gastrointestinal Diseases; Humans; Peptic Ulcer | 1968 |
143 other study(ies) available for bismuth and Gastroduodenal Ulcer
| Article | Year |
|---|---|
Effects of Quadruple Therapy Combined with Probiotics on
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Motilin; Pectins; Peptic Ulcer; Probiotics; Proton Pump Inhibitors; Somatostatin; Tablets, Enteric-Coated | 2022 |
Barry Marshall, MD: H pylori 35 Years Later.
Topics: Anniversaries and Special Events; Antacids; Anti-Bacterial Agents; Asthma; Bacterial Vaccines; Bismuth; Drug Resistance, Bacterial; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Nobel Prize; Organometallic Compounds; Peptic Ulcer; Probiotics; Salicylates; Stress, Psychological | 2017 |
Comparison of antimicrobial activity of zinc chloride and bismuth subsalicylate against clinical isolates of Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Bismuth; Chlorides; Chronic Disease; Clarithromycin; Drug Resistance, Bacterial; Dyspepsia; Female; Gastric Juice; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Microbial Sensitivity Tests; Middle Aged; Organometallic Compounds; Peptic Ulcer; Salicylates; Zinc Compounds | 2014 |
[Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition].
Topics: Amoxicillin; Anti-Bacterial Agents; Aspirin; Bismuth; Breath Tests; Clarithromycin; Gastroesophageal Reflux; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Metaplasia; Metronidazole; Peptic Ulcer; Proton Pump Inhibitors; Republic of Korea; Stomach Neoplasms; Tetracycline | 2013 |
[Quadruple therapy is more effective against H. pylori].
Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer; Proton Pump Inhibitors | 2016 |
[Diagnosis and treatment guidelines for Helicobacter pylori infection in Korea].
Topics: Amoxicillin; Antacids; Anti-Infective Agents; Bismuth; Breath Tests; Clarithromycin; Enzyme-Linked Immunosorbent Assay; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer; Proton Pump Inhibitors; Stomach Neoplasms; Tetracycline | 2009 |
[Guidelines of treatment for non-bleeding peptic ulcer disease].
Topics: Antacids; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Bismuth; Helicobacter Infections; Helicobacter pylori; Histamine Antagonists; Humans; Peptic Ulcer; Proton Pump Inhibitors | 2009 |
Double-liposome-based dual-drug delivery system as vectors for effective management of peptic ulcer.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Delayed-Action Preparations; Drug Carriers; Drug Combinations; Drug Stability; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Liposomes; Male; Microbial Sensitivity Tests; Particle Size; Peptic Ulcer; Ranitidine; Rats | 2012 |
Bismuth subcitrate/metronidazole/ tetracycline--Axcan Pharma. Bismuth triple therapy--Axcan Pharma, Helicide.
Topics: Anti-Bacterial Agents; Bismuth; Drug Combinations; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Organometallic Compounds; Peptic Ulcer; Tetracycline | 2002 |
Gastric spirochaetes: 100 years of discovery before and after Kobayashi.
Topics: Animals; Bacteriology; Bismuth; Helicobacter pylori; History, 20th Century; Humans; Peptic Ulcer; Stomach; Urease | 2002 |
Therapeutic efficacy of ranitidine bismuth citrate with clarithromycin for seven days in the eradication of Helicobacter pylori in Brazilian peptic ulcer patients.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Brazil; Clarithromycin; Cross-Sectional Studies; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Peptic Ulcer; Ranitidine | 2003 |
The fate of bismuth carbonate in the stomach; a radiological study.
Topics: Antacids; Bismuth; Carbonates; Humans; Peptic Ulcer; Stomach | 1954 |
[Clinical experiences with ultox in the current therapy of inflammation of the gastric mucosa, with special reference to ulcus ventriculi and duodeni].
Topics: Antacids; Bismuth; Gastric Mucosa; Gastritis; Humans; Inflammation; Magnesium Oxide; Peptic Ulcer; Stomach Ulcer | 1954 |
[The treatment of duodenal ulcer with bismuth].
Topics: Antacids; Antidiarrheals; Bismuth; Duodenal Ulcer; Humans; Peptic Ulcer | 1954 |
Treatment of peptic ulcers with roter tablets.
Topics: Antacids; Antidiarrheals; Bismuth; Humans; Peptic Ulcer; Tablets | 1955 |
[Comparative action of the protective effects of various forms of bismuth subnitrate (colloidal and ordinary) in experimental gastric ulcer of the rat].
Topics: Animals; Antacids; Antidiarrheals; Bismuth; Peptic Ulcer; Rats; Stomach Ulcer | 1956 |
Improved therapy for peptic ulcers.
Topics: Antacids; Bicarbonates; Bismuth; Humans; Peptic Ulcer; Plant Extracts | 1957 |
[Experience in the treatment of gastrointestinal diseases with roter tablets].
Topics: Antacids; Bicarbonates; Bismuth; Gastritis; Gastrointestinal Diseases; Humans; Nitrates; Peptic Ulcer; Tablets | 1958 |
[The parenteral treatment of duodenal ulcer with bismuth].
Topics: Antacids; Antidiarrheals; Bismuth; Duodenal Ulcer; Humans; Peptic Ulcer | 1960 |
Peptic ulcers induced in white rats by reserpine and stress. The protective action of roterized bismuth subnitrate.
Topics: Animals; Antacids; Bismuth; Peptic Ulcer; Rats; Reserpine; Stress, Physiological | 1961 |
[Is parenteral injection necessary in the treatment of the ulcerous crisis? Comparative study of the action of 2,2-diphenyl-4-diisopropylaminobutyramide methyliodide, of bismuth and of sodium oxyferriscorbone on the painful ulcerous crisis].
Topics: 2,3-Diketogulonic Acid; Alloxan; Antacids; Biphenyl Compounds; Bismuth; Drug Combinations; Ferric Compounds; Infusions, Parenteral; Parasympatholytics; Peptic Ulcer | 1961 |
[Apropos of the protective properties of micellar bismuth against experimental ulcers induced in albino rats by reserpine administration or by constraint].
Topics: Animals; Antacids; Antidiarrheals; Bismuth; Peptic Ulcer; Rats; Reserpine; Stress, Physiological; Ulcer | 1961 |
[Preliminary communication on the application of the bismuth radioisotope Bi-210 in gastric diseses].
Topics: Bismuth; Gastritis; Humans; Peptic Ulcer; Radioisotopes | 1959 |
Medical treatment of peptic ulcer.
Topics: Antacids; Antidiarrheals; Bismuth; Humans; Peptic Ulcer | 1963 |
[Experiences with the licorice juice preparation Caved-S in the treatment of ulcers of the gastrointestinal tract].
Topics: Aluminum Hydroxide; Bismuth; Drug Combinations; Glycyrrhiza; Humans; Magnesium Hydroxide; Peptic Ulcer; Plant Extracts; Sodium Bicarbonate; Ulcer | 1963 |
[Current orientations of the medical treatment of gastroduodenal ulcer disease].
Topics: Antacids; Antidiarrheals; Bismuth; Peptic Ulcer | 1963 |
[Gastroduodenal ulcer].
Topics: Antacids; Antidiarrheals; Bismuth; Humans; Magnesium Oxide; Peptic Ulcer; Plants, Medicinal | 1962 |
[The treatment of gastroduodenal disorders with bismuth aluminum carbonate].
Topics: Aluminum; Antacids; Bismuth; Carbonates; Duodenal Diseases; Humans; Peptic Ulcer; Stomach | 1962 |
[TREATMENT OF PEPTIC ULCER PATIENTS WITH VIKALIN].
Topics: Anions; Antacids; Bicarbonates; Bismuth; Carbonates; Duodenal Ulcer; Humans; Khellin; Magnesium; Peptic Ulcer; Plants, Medicinal; Rutin; Sodium; Stomach Ulcer | 1963 |
[ON THE THERAPY OF GASTRIC DISEASES WITH OTREON].
Topics: Antacids; Bismuth; Gastritis; Humans; Magnesium; Papaverine; Peptic Ulcer; Postgastrectomy Syndromes | 1963 |
[ON THE ANTIPEPTIC ACTIVITY OF DRUGS].
Topics: Antacids; Bismuth; Carbonates; Carrageenan; Gastric Juice; Hydroxides; Nitrates; Pepsin A; Peptic Ulcer; Pharmacology; Polysaccharides; Pylorus; Rats; Research; Sulfates; Tyrosine | 1964 |
DOUBLE-BLIND TRIAL OF BISMUTH ALUMINATE AND MAGNESIUM TRISILICATE IN PEPTIC ULCERATION WITH SIMULTANEOUS GASTRIC ANALYSIS.
Topics: Aluminum; Antacids; Biomedical Research; Bismuth; Double-Blind Method; Drug Therapy; Gastric Acidity Determination; Humans; Magnesium; Magnesium Silicates; Pepsin A; Peptic Ulcer; Statistics as Topic | 1965 |
INITIAL EVALUATION OF A NEW BISMUTH COMPOUND IN THE THERAPY OF PEPTIC ULCER WITH IN VIVO GASTRIC ANALYSIS.
Topics: Bismuth; Drug Therapy; Gastric Acidity Determination; Humans; Peptic Ulcer | 1965 |
ACTION OF BISMUTH ALUMINATE.
Topics: Aluminum; Antacids; Antidiarrheals; Aspirin; Bismuth; Cats; Gastric Acidity Determination; Gastric Mucosa; Peptic Ulcer; Pharmacology; Research | 1965 |
[Experimental study of the cicatrizing action of bismuth in supercolloidal dispersion of ulcerative lesions of the gastroduodenal wall].
Topics: Antacids; Bismuth; Cicatrix; Peptic Ulcer | 1954 |
[Spectrophotometric research on bismuth in carcinoma and in round ulcers of the stomach in patients treated with bismuth-lecithin camphocarbonate].
Topics: Antacids; Bismuth; Carcinoma; Humans; Lecithins; Peptic Ulcer; Phosphatidylcholines; Stomach Neoplasms; Ulcer | 1962 |
[Use of Roter in peptic ulcer of the stomach and duodenum].
Topics: Antacids; Bismuth; Carbonates; Duodenum; Humans; Peptic Ulcer; Rhamnus | 1962 |
Information from your family doctor. Ulcers and Helicobacter pylori infection.
Topics: Abdominal Pain; Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti-Ulcer Agents; Bismuth; Drug Combinations; Family Practice; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer; Ranitidine | 2003 |
[Large bismuth dosages in treatment of chronic peptic ulcer].
Topics: Bismuth; Peptic Ulcer | 1950 |
[The trend of eradication rates of second-line quadruple therapy containing metronidazole for Helicobacter pylori infection: an analysis of recent eight years].
Topics: Adult; Antacids; Anti-Infective Agents; Bismuth; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Proton Pump Inhibitors; Recurrence; Tetracycline | 2005 |
Helicobacter pylori eradication in peptic dyspepsia.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine | 2005 |
Problems associated with medical treatment of peptic ulcer disease.
Topics: Aluminum; Antacids; Anti-Ulcer Agents; Antidepressive Agents, Tricyclic; Benzimidazoles; Bismuth; Carbenoxolone; Cimetidine; Colloids; Female; Humans; Male; Parasympatholytics; Peptic Ulcer; Prostaglandins; Ranitidine; Sucralfate | 1984 |
Another look at peptic ulcer.
Topics: Antacids; Bismuth; Chronic Disease; Cimetidine; Colloids; Duodenal Ulcer; Female; Furans; Histamine H2 Antagonists; Humans; Male; Middle Aged; Peptic Ulcer; Ranitidine; Stomach Ulcer | 1981 |
Drug therapy for peptic ulcer: drugs that act on the gastric mucosa.
Topics: Antacids; Anti-Ulcer Agents; Bismuth; Carbenoxolone; Cimetidine; Dinoprostone; Gastric Mucosa; Histamine H2 Antagonists; Humans; Peptic Ulcer; Prostaglandins E | 1981 |
[Innovations in the treatment of gastroduodenal ulcers].
Topics: Aluminum; Antacids; Anti-Ulcer Agents; Benzodiazepinones; Bismuth; Cimetidine; Furans; Humans; Organometallic Compounds; Peptic Ulcer; Pirenzepine; Placebos; Prostaglandins; Ranitidine; Sucralfate | 1983 |
[Therapy of peptic ulcer with cytoprotective substances].
Topics: Aluminum; Arbaprostil; Bismuth; Carbenoxolone; Cimetidine; Glycyrrhetinic Acid; Humans; Pepsin A; Peptic Ulcer; Sucralfate | 1983 |
The treatment of peptic ulcer.
Topics: Anti-Ulcer Agents; Bismuth; Cimetidine; Diagnosis, Differential; Dyspepsia; Humans; Organometallic Compounds; Peptic Ulcer | 1982 |
Cimetidine and malabsorption of cobalamin.
Topics: Anti-Ulcer Agents; Bismuth; Cimetidine; Guanidines; Humans; Intestinal Absorption; Intrinsic Factor; Male; Organometallic Compounds; Peptic Ulcer; Vitamin B 12; Vitamin B 12 Deficiency | 1982 |
[Is bismuth subcitrate an effective drug for the patient with peptic ulcer?].
Topics: Anti-Ulcer Agents; Bismuth; Cimetidine; Humans; Organometallic Compounds; Peptic Ulcer; Tablets | 1982 |
The medical treatment of chronic gastric and duodenal ulceration.
Topics: Antacids; Bismuth; Cimetidine; Colloids; Duodenal Ulcer; Humans; Peptic Ulcer; Stomach Ulcer | 1981 |
The modern treatment of peptic ulceration.
Topics: Antacids; Bismuth; Carbenoxolone; Cimetidine; Duodenal Ulcer; Guanidines; Humans; Peptic Ulcer; Recurrence; Stomach Ulcer | 1981 |
An unusual radiographic presentation of colonic carcinoma after medication for peptic ulcer.
Topics: Adenocarcinoma; Aged; Bismuth; Colonic Neoplasms; Female; Humans; Peptic Ulcer; Radiography | 1980 |
[Helicobacter pylori and peptic ulcer--1995 therapeutic indications and recommendations of a Munster Expert Group].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Ranitidine; Salicylates; Tetracycline | 1995 |
[Characteristics of the effects of de-nol on the course of erosive-ulcerative lesions of the esophagus, stomach and duodenum associated with Helicobacter pylori].
Topics: Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Duodenitis; Evaluation Studies as Topic; Gastritis; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Peptic Ulcer; Stomach Ulcer; Time Factors | 1995 |
90% cure: which anti-Helicobacter therapy can achieve this treatment goal?
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer; Randomized Controlled Trials as Topic; Tetracycline | 1995 |
Toward an optimal treatment of Helicobacter pylori-positive peptic ulcers.
Topics: Bismuth; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer | 1995 |
Helicobacter pylori eradication and reinfection.
Topics: Anti-Bacterial Agents; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer; Peptic Ulcer Hemorrhage; Recurrence | 1995 |
Helicobacter pylori eradication and reinfection.
Topics: Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer; Tetracycline | 1995 |
Helicobacter pylori: a human pathogen.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer | 1995 |
The gastroduodenal mucus barrier and its role in protection against luminal pepsins: the effect of 16,16 dimethyl prostaglandin E2, carbopol-polyacrylate, sucralfate and bismuth subsalicylate.
Topics: 16,16-Dimethylprostaglandin E2; Acrylic Resins; Animals; Bismuth; Duodenum; Gastric Mucosa; Intestinal Mucosa; Male; Mucus; Organometallic Compounds; Pepsin A; Peptic Ulcer; Rats; Rats, Wistar; Salicylates; Sucralfate | 1994 |
Effective treatment after failure of omeprazole plus amoxycillin to eradicate Helicobacter pylori infection in peptic ulcer disease.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Amoxicillin; Bismuth; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Ranitidine; Recurrence; Salicylates; Tetracycline; Treatment Failure; Treatment Outcome | 1994 |
[10 days of triple treatment of Helicobacter pylori infection and peptic ulcer. Status after treatment of 4 weeks and of one year].
Topics: Adult; Aged; Bismuth; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Oxytetracycline; Peptic Ulcer; Time Factors | 1994 |
[A Norwegian conference on updating of the treatment of Helicobacter pylori in peptic ulcer. Interessegruppe for Gastroenterologi].
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Norway; Omeprazole; Oxytetracycline; Peptic Ulcer | 1994 |
Clarithromycin, tetracycline, and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection.
Topics: Adult; Aged; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Organometallic Compounds; Peptic Ulcer; Ranitidine; Salicylates; Tetracycline; Time Factors | 1994 |
Helicobacter pylori infection and serum pepsinogen A, pepsinogen C, and gastrin in gastritis and peptic ulcer: significance of inflammation and effect of bacterial eradication.
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Female; Gastrins; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Pepsinogens; Peptic Ulcer; Salicylates | 1994 |
H. pylori and ulcers.
Topics: Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Peptic Ulcer; Salicylates | 1994 |
Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Peptic Ulcer Hemorrhage; Prospective Studies; Ranitidine; Recurrence; Salicylates; Stomach Ulcer | 1994 |
[Helicobacter and peptic ulcer: history, diagnosis and therapy--when, in whom and how?].
Topics: Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer | 1994 |
Helicobacter pylori infection and exaggerated gastrin release. Effects of inflammation and progastrin processing.
Topics: Adult; Bismuth; Female; Food; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Organometallic Compounds; Peptic Ulcer; Protein Precursors; Protein Processing, Post-Translational; Salicylates; Tetracycline | 1993 |
[Helicobacter pylori infection and peptic ulcer].
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer; Tetracycline | 1993 |
Therapeutics used to alleviate peptic ulcers inhibit H. pylori receptor binding in vitro.
Topics: Anti-Ulcer Agents; Bacterial Adhesion; Bismuth; Carbohydrate Sequence; Detergents; Gangliosides; Glycosphingolipids; Helicobacter pylori; Molecular Sequence Data; Peptic Ulcer; Phosphatidylethanolamines | 1993 |
[Skin disorders caused by bismuth oxide (De-Nol)].
Topics: Adult; Aged; Bismuth; Drug Eruptions; Female; Humans; Male; Middle Aged; Peptic Ulcer | 1994 |
Esophagitis and Helicobacter pylori in children: incidence and therapeutic implications.
Topics: Adolescent; Amoxicillin; Bismuth; Child; Cimetidine; Esophagitis; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Peptic Ulcer; Pyloric Antrum; Ranitidine | 1993 |
Evaluation of a new bismuth-free triple therapy in nude mice and humans.
Topics: Amoxicillin; Animals; Anti-Ulcer Agents; Antitrichomonal Agents; Bismuth; Colony Count, Microbial; Contraindications; Disease Models, Animal; Diterpenes; Drug Therapy, Combination; Fatty Alcohols; Gastritis; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Mice; Mice, Inbred BALB C; Mice, Nude; Penicillins; Peptic Ulcer; Recurrence; Severity of Illness Index; Treatment Outcome | 1995 |
Management of Helicobacter pylori-positive peptic ulcer disease.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer | 1996 |
[Diagnosis and therapy of Helicobacter pylori infection. Guidelines of the German Society of Digestive and Metabolic Diseases].
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Child; Drug Therapy, Combination; Gastritis; Germany; Helicobacter Infections; Humans; Peptic Ulcer; Stomach Neoplasms; Treatment Outcome | 1996 |
Practice guidelines for treatment of peptic ulcer disease.
Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Peptic Ulcer; Practice Guidelines as Topic; Ranitidine | 1996 |
[Anti-Helicobacter pylori therapy. Who should be treated, how, how long?].
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer; Treatment Outcome | 1996 |
Six months' experience with a pharmacist-run Helicobacter pylori treatment clinic.
Topics: Amoxicillin; Anti-Bacterial Agents; Antitrichomonal Agents; Bismuth; Cost of Illness; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Pilot Projects; Salicylates; Tetracycline | 1996 |
A one-week quadruple eradication regimen for Helicobacter pylori in routine clinical practice.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Tetracycline | 1997 |
Identification and eradication of Helicobacter pylori in an isolated patient population.
Topics: Amoxicillin; Bismuth; Cost Savings; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Metronidazole; Military Personnel; Organometallic Compounds; Peptic Ulcer; Salicylates; Tetracycline; United States; Utah | 1997 |
Simplified 10-day bismuth triple therapy for cure of Helicobacter pylori infection: experience from clinical practice in a population with a high frequency of metronidazole resistance.
Topics: Adult; Aged; Aged, 80 and over; Antacids; Anti-Bacterial Agents; Bismuth; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Oxytetracycline; Peptic Ulcer | 1998 |
Significance of a tetracycline and Pepto-Bismol interaction in the management of Helicobacter pylori-induced peptic ulcer disease.
Topics: Bismuth; Drug Interactions; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Peptic Ulcer; Salicylates; Tetracycline | 1998 |
Peptic ulcer treatment today--is there a role for maintenance therapy?
Topics: Antacids; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Bismuth; Chronic Disease; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Peptic Ulcer; Peptic Ulcer Hemorrhage; Recurrence | 1997 |
Treating Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Combinations; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Ranitidine | 1998 |
The pharmacoeconomic impact of antimicrobial therapy for peptic ulcer disease in a large urban jail.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; New York City; Organometallic Compounds; Peptic Ulcer; Prisons; Ranitidine; Retrospective Studies; Salicylates; Tetracycline; Urban Health | 1998 |
Organobismuth compounds: activity against Helicobacter pylori.
Topics: Bismuth; Helicobacter Infections; Helicobacter pylori; Humans; Inorganic Chemicals; Microbial Sensitivity Tests; Organic Chemicals; Peptic Ulcer | 1999 |
[Intensifying the study of the proper treatment of digestive ulceration].
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Peptic Ulcer | 1997 |
CYP2C19 genotype-related efficacy of omeprazole for the treatment of infection caused by Helicobacter pylori.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Bismuth; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Enzyme Inhibitors; Gastritis; Genotype; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Metronidazole; Mixed Function Oxygenases; Omeprazole; Penicillins; Peptic Ulcer; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Protein Synthesis Inhibitors; Treatment Outcome | 1999 |
Dual therapy with ranitidine bismuth citrate for Helicobacter pylori eradication.
Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Peptic Ulcer; Ranitidine | 2001 |
[Conservative treatment of peptic ulcer disease (author's transl)].
Topics: Bismuth; Glycyrrhiza; Histamine H2 Antagonists; Humans; Metoclopramide; Peptic Ulcer; Plants, Medicinal; Prostaglandins | 1977 |
Editorial: Bismuth and ulcers.
Topics: Bismuth; Drug Evaluation; Humans; Peptic Ulcer | 1975 |
Drugs for peptic ulcer.
Topics: Antacids; Bismuth; Carbenoxolone; Chelating Agents; Cimetidine; Duodenal Neoplasms; Duodenal Ulcer; Humans; Peptic Ulcer; Peptic Ulcer Hemorrhage; Stomach Neoplasms; Stomach Ulcer | 1979 |
Treatment of peptic ulcer disease- a symposium.
Topics: Antacids; Bismuth; Humans; Parasympatholytics; Peptic Ulcer; Prostaglandins E | 1977 |
The treatment of dyspepsia.
Topics: Antacids; Bismuth; Carbenoxolone; Cimetidine; Dyspepsia; Esophagitis; Humans; Metoclopramide; Parasympatholytics; Peptic Ulcer | 1977 |
Tri-potassium di-citrato bismuthate: a report of its pharmacological properties and therapeutic efficacy in peptic ulcer.
Topics: Animals; Anti-Ulcer Agents; Bismuth; Dogs; Dose-Response Relationship, Drug; Drug Evaluation; Drug Evaluation, Preclinical; Duodenal Ulcer; Female; Humans; Male; Peptic Ulcer; Rats; Stomach Ulcer | 1976 |
Protective effect of Pepto-Bismol liquid on the gastric mucosa of rats.
Topics: Animals; Aspirin; Bismuth; Cold Temperature; Disease Models, Animal; Ethanol; Gastric Mucosa; Peptic Ulcer; Rats | 1975 |
[Drug therapy of peptic ulcer].
Topics: Antacids; Bicarbonates; Bismuth; Calcium Carbonate; Humans; Magnesium Oxide; Parasympatholytics; Peptic Ulcer | 1975 |
[Evaluation of antipeptic effect of medicinal preparations in treatment of ulcer disease].
Topics: Atropine; Bismuth; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Peptic Ulcer | 1976 |
Eradication of Helicobacter pylori reduces gastric and duodenal ulcer recurrence.
Topics: Bismuth; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Organometallic Compounds; Peptic Ulcer; Ranitidine; Recurrence; Salicylates; Tetracycline | 1992 |
Bismuth absorption from 205Bi-labelled pharmaceutical bismuth compounds used in the treatment of peptic ulcer disease.
Topics: Adult; Aluminum; Anti-Ulcer Agents; Biological Availability; Bismuth; Female; Gallic Acid; Humans; Intestinal Absorption; Male; Middle Aged; Nitrates; Organometallic Compounds; Peptic Ulcer; Radioisotopes | 1992 |
Drugs for treatment of peptic ulcers.
Topics: Antacids; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Histamine H2 Antagonists; Humans; Misoprostol; Omeprazole; Peptic Ulcer; Sucralfate | 1991 |
[Assessment of the efficacy of de-nol and bismuth subnitrate treatment of patients with associated peptic ulcer and pyloric Helicobacter infection (experimental and clinical studies)].
Topics: Adult; Animals; Anti-Ulcer Agents; Bismuth; Helicobacter Infections; Helicobacter pylori; Humans; Microscopy, Electron, Scanning; Middle Aged; Organometallic Compounds; Peptic Ulcer; Pyloric Antrum; Rats | 1991 |
Cytoprotection and stress ulceration.
Topics: Bismuth; Carbenoxolone; Gastric Mucosa; Gastrointestinal Hemorrhage; Humans; Peptic Ulcer; Prostaglandins; Regional Blood Flow; Stress, Psychological; Sucralfate | 1991 |
[Helicobacter pylori, peptic diseases and colloid bismuth].
Topics: Bismuth; Dyspepsia; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer | 1990 |
[Controversy: the role of Helicobacter pilori in gastroduodenal pathology].
Topics: Bismuth; Campylobacter Infections; Gastritis; Humans; Metaplasia; Peptic Ulcer; Pylorus | 1990 |
[The role of Helicobacter pilori: reasons to believe it].
Topics: Anti-Bacterial Agents; Bismuth; Campylobacter Infections; Dyspepsia; Gastritis; Humans; Peptic Ulcer | 1990 |
Campylobacter pylori and gastroduodenal ulcer disease. A prospective study in a Swedish population.
Topics: Adult; Aged; Aged, 80 and over; Aluminum Hydroxide; Anti-Ulcer Agents; Bismuth; Campylobacter Infections; Drug Combinations; Female; Glycyrrhiza; Histamine H2 Antagonists; Humans; Magnesium Hydroxide; Male; Middle Aged; Peptic Ulcer; Pilot Projects; Plant Extracts; Prospective Studies; Sodium Bicarbonate; Sweden | 1989 |
[Campylobacter pylori associated gastritis].
Topics: Bismuth; Campylobacter; Campylobacter Infections; Gastric Mucosa; Gastritis; Humans; Peptic Ulcer | 1989 |
[Diagnosis and treatment of gastric campylobacteriosis in patients with peptic ulcer and chronic gastritis].
Topics: Adult; Aged; Anti-Bacterial Agents; Bismuth; Campylobacter Infections; Chronic Disease; Female; Gastritis; Humans; Male; Middle Aged; Peptic Ulcer | 1989 |
Peptic ulcer disease: physiology and pathophysiology.
Topics: Antacids; Aspirin; Bismuth; Duodenal Ulcer; Gastric Acid; Gastric Mucosa; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Parasympatholytics; Parietal Cells, Gastric; Pepsinogens; Peptic Ulcer; Prostaglandins; Smoking; Stomach; Stomach Ulcer | 1985 |
[Ulcer healing without acid inhibition].
Topics: Aluminum; Bismuth; Carbenoxolone; Gastric Acid; Histamine H2 Antagonists; Humans; Organometallic Compounds; Peptic Ulcer; Recurrence; Sucralfate; Trimipramine | 1985 |
Acid rules--or does it?
Topics: Anti-Ulcer Agents; Bismuth; Gastric Acid; Histamine H2 Antagonists; Humans; Organometallic Compounds; Peptic Ulcer; Ranitidine; Sucralfate | 1986 |
[Morphologic change in Campylobacter pylori associated gastritis in and following successful antibacterial therapy].
Topics: Amoxicillin; Bismuth; Campylobacter Infections; Drug Therapy, Combination; Gastric Mucosa; Gastritis; Humans; Metronidazole; Organometallic Compounds; Peptic Ulcer; Salicylates | 1989 |
Cytoprotective and ulcer healing properties of prostaglandin E2, colloidal bismuth and sucralfate in rats.
Topics: Animals; Bismuth; Chronic Disease; Dinoprostone; Disease Models, Animal; Gastric Acid; Gastric Mucosa; Gastrins; Male; Pepsin A; Peptic Ulcer; Prostaglandins E; Rats; Rats, Inbred Strains; Sucralfate | 1987 |
Bismuth is better.
Topics: Antacids; Bismuth; Humans; Organometallic Compounds; Peptic Ulcer | 1988 |
Epidermal growth factor (EGF) in the gastroprotective and ulcer healing actions of colloidal bismuth subcitrate (De-Nol) in rats.
Topics: 16,16-Dimethylprostaglandin E2; Animals; Anti-Ulcer Agents; Bismuth; Epidermal Growth Factor; ErbB Receptors; Gastric Mucosa; Male; Organometallic Compounds; Peptic Ulcer; Rats; Rats, Inbred Strains; Submandibular Gland | 1988 |
Stress ulcer prophylaxis and ventilation pneumonia: prevention by antibacterial cytoprotective agents?
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Gastric Juice; Humans; Hydrogen-Ion Concentration; Organometallic Compounds; Peptic Ulcer; Pneumonia; Prospective Studies; Respiration, Artificial; Risk Factors; Salicylates; Stress, Physiological; Sucralfate; Trachea | 1988 |
De-Nol: a new concept in cytoprotection. Proceedings from an international symposium. Milan, Italy, 13 November 1985.
Topics: Anti-Ulcer Agents; Bismuth; Humans; Organometallic Compounds; Peptic Ulcer | 1986 |
Gastroprotection by antisecretory and non-antisecretory agents.
Topics: Animals; Anti-Ulcer Agents; Bismuth; Carbenoxolone; Gastrointestinal Hormones; Humans; Organometallic Compounds; Peptic Ulcer; Prostaglandins; Sucralfate | 1986 |
The safety profile of De-Nol.
Topics: Anti-Ulcer Agents; Bismuth; Humans; Organometallic Compounds; Peptic Ulcer | 1987 |
[Is chronic gastritis an infection and does it pave the way for peptic ulcer disease?].
Topics: Bacterial Infections; Bismuth; Campylobacter; Campylobacter Infections; Gastritis; Humans; Peptic Ulcer | 1987 |
[Therapy of peptic ulcer and chronic gastritis with bismuth salts].
Topics: Anti-Ulcer Agents; Bismuth; Campylobacter Infections; Chronic Disease; Duodenal Ulcer; Gastritis; Humans; Organometallic Compounds; Peptic Ulcer; Salicylates; Stomach Ulcer | 1987 |
Interaction of tripotassium dicitrato bismuthate with macrophages in the rat and in vitro.
Topics: Animals; Bismuth; Female; In Vitro Techniques; Macrophages; Male; Organometallic Compounds; Peptic Ulcer; Rats | 1986 |
Cytoprotective agents and ulcer relapse.
Topics: Aluminum; Antacids; Bismuth; Carbenoxolone; Cimetidine; Duodenal Ulcer; Humans; Organometallic Compounds; Peptic Ulcer; Recurrence; Stomach Ulcer; Sucralfate | 1985 |
[Ulgastrin rolling cure for the treatment of inflammatory diseases of the gastrointestinal tract].
Topics: Adult; Aged; Aluminum Silicates; Antacids; Anti-Inflammatory Agents; Bismuth; Female; Gastritis; Glycyrrhiza; Humans; Hydrocarbons; Male; Middle Aged; Peptic Ulcer; Plants, Medicinal; Silicon Dioxide; Sodium; Sulfates | 1968 |
A successful management of the peptic ulcer patient in industry.
Topics: Atropa belladonna; Bismuth; Occupational Diseases; Peptic Ulcer; Phytotherapy; Plants, Medicinal; Plants, Toxic; Scopolamine | 1966 |
[Preventing exacerbation of peptic ulcer].
Topics: Adult; Antihypertensive Agents; Ascorbic Acid; Bismuth; Bromides; Carbonates; Female; Ganglionic Blockers; Humans; Magnesium; Male; Middle Aged; Papaverine; Peptic Ulcer; Plants, Toxic; Senecio; Vitamin B Complex | 1967 |
[Dynamics of indices of gastric secretion during therapy of peptic ulcer].
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Bismuth; Carbonates; Female; Ganglionic Blockers; Gastric Juice; Gastric Mucosa; Hexamethonium Compounds; Honey; Humans; Magnesium; Male; Middle Aged; Mineral Waters; Peptic Ulcer; Plants, Toxic; Pyridoxine; Senecio; Tissue Extracts | 1971 |
A multi-centre pilot study of tri-potassium di-citrato bismuthate ('De-Nol') in general practice.
Topics: Administration, Oral; Adolescent; Adult; Aged; Bismuth; Citrates; Duodenal Ulcer; Family Practice; Female; Gastrointestinal Agents; Humans; Male; Middle Aged; Pain; Peptic Ulcer; Pilot Projects; Radiography; Stomach Ulcer; Vomiting | 1973 |
[Certain data of clinical course and diagnosis of ulcer disease in children].
Topics: Adolescent; Bismuth; Child; Child, Preschool; Diathermy; Diet Therapy; Humans; Mineral Waters; Peptic Ulcer; Thiamine | 1974 |
Editorial: Drugs for gastric ulceration.
Topics: Bismuth; Cholestyramine Resin; Diethylstilbestrol; Diuresis; Dose-Response Relationship, Drug; Glycyrrhiza; Humans; Hypertension; Hypokalemia; Peptic Ulcer; Plants, Medicinal; Smoking; Spironolactone; Squalene; Terpenes | 1974 |
Ulcerine and treatment of peptic ulcer.
Topics: Amylases; Atropa belladonna; Bismuth; Buffers; Citrates; Humans; Pepsin A; Peptic Ulcer; Phytotherapy; Plants, Medicinal; Plants, Toxic; Quaternary Ammonium Compounds | 1971 |
Peptic ulcer--a simplified ambulatory therapy.
Topics: Ambulatory Care; Bismuth; Humans; Parasympatholytics; Peptic Ulcer; Quaternary Ammonium Compounds | 1970 |
An endoscopic evaluation of gastric ulcer treated with a mixture containing bismuth ammonium citrate.
Topics: Adult; Aged; Atropa belladonna; Bismuth; Female; Gastroscopy; Humans; Male; Middle Aged; Peptic Ulcer; Phytotherapy; Plants, Medicinal; Plants, Toxic; Quaternary Ammonium Compounds | 1970 |
[What is secured in the treatment of peptic ulcer?].
Topics: Antacids; Bismuth; Calcium Carbonate; Diet Therapy; Glycyrrhiza; Humans; Magnesium Oxide; Parasympatholytics; Peptic Ulcer; Plants, Medicinal; Promethazine; Recurrence | 1972 |
[Study on a new protective agent of gastro-duodenal mucous membrane].
Topics: Adolescent; Adult; Aged; Antacids; Bismuth; Duodenal Diseases; Female; Gastrointestinal Diseases; Hernia, Diaphragmatic; Humans; Male; Middle Aged; Peptic Ulcer; Plants, Medicinal; Procaine; Stomach Diseases; Stomach Neoplasms | 1967 |
[Clinical experimentation with Trisibam].
Topics: Bismuth; Diarrhea; Gastrectomy; Gastrointestinal Diseases; Humans; Magnesium; Peptic Ulcer; Postoperative Complications; Sodium | 1967 |
[Stomach and duodenal ulcer, a new therapeutic approach with Vit-U-Peptinjections].
Topics: Animals; Bismuth; Carbonates; Dogs; Female; Guinea Pigs; Humans; Injections, Intravenous; Magnesium; Male; Peptic Ulcer; Plant Extracts; Plants, Medicinal; Sodium | 1968 |
[Treatment of gastroduodenal ulcer using bismoprimperan].
Topics: Adult; Amides; Bismuth; Humans; Male; Middle Aged; Peptic Ulcer | 1968 |
[Treatment of patients with peptic ulcer].
Topics: Adolescent; Adult; Bismuth; Carbonates; Female; Humans; Magnesium; Male; Middle Aged; Peptic Ulcer | 1968 |
[The practitioner and the medical treatment of the gastro-duodenal ulcer].
Topics: Amino Acids; Analgesics; Anti-Inflammatory Agents; Ascorbic Acid; Atropine; Bismuth; Carbonates; Diet Therapy; Gastric Mucins; Humans; Imipramine; Injections, Intravenous; Muscles; Nitrates; Parasympatholytics; Parathyroid Hormone; Peptic Ulcer; Piperazines; Polysaccharides; Proteins; Secretin; Tissue Extracts | 1969 |
[Treatment of gastroduodenal ulcer using a combined method].
Topics: Bicarbonates; Bismuth; Blood Transfusion; Carbonates; Magnesium; Peptic Ulcer | 1965 |